https://www.indianpharmapost.com/biocon-reports-a-consolidated-net-profit-of-rs-1383-crore-in-q2fy22-104972021-10-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/lupin-enters-guinness-records-highlights-rise-in-strokes-105062021-10-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/biocon-q2fy22-in-line-with-estimates-better-margins-icici-direct-105072021-10-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/syngene-reports-better-than-expected-revenues-margin-pressure-in-q1fy22-icici-direct-105082021-10-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/roches-susvimo-for-wet-age-related-macular-degeneration-namd-approved-105092021-10-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/india-ramps-up-medical-education-with-substantial-investments-105102021-10-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/qurhealth-launch-patient-care-concierge-programme-in-india-105112021-10-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/novartis-cancer-drug-trial-does-not-meet-primary-end-points-105122021-10-25T00:00:00+05:30always0.9